India to China: Diagnostic Export Trade Route

The India to China Diagnostic corridor is one of India's established pharmaceutical export routes, with 141 shipments documented worth a combined $1.5M USD. The route is dominated by AURACARE PHARMA AND BIOTECH, which alone accounts for roughly 32% of all export value, reflecting the consolidated nature of India's diagnostic manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $10.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 85% of all shipments, consistent with diagnostic's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 24.1%, placing it at rank #12 among India's top diagnostic export destinations globally.

On the import side, key buyers of Indian diagnostic in China include NA, Guangdong Fapon Biotech Co,Ltd , Shenzhen New Industries Biomedical and 35 others. NA is the single largest importer with 7 shipments valued at $732.2K USD.

India's diagnostic exports to China are driven primarily by a handful of large-scale manufacturers. AURACARE PHARMA AND BIOTECH with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in China benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — AURACARE PHARMA AND BIOTECH, ADVY CHEMICAL PRIVATE LIMITED , ADVY CHEMICAL PRIVATE LIMITED — together account for 72% of total trade value on this route. The average shipment value of $10.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as ck mm diagnostics grade as per inv and diagnostic reagents c reactive protein , suggesting that buyers in China tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NA is the largest importer with 7 shipments worth $732.2K USD — representing 49% of all diagnostic imports from India on this route. A total of 38 buyers are active on this corridor.